Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OptimEyes: Optina in Diabetic Macular Edema
NCT01821677Phase 2Completed
- Sponsor
- Ampio Pharmaceuticals, Inc.
- Start
- Feb 2013
- Primary completion
- Oct 2014
- Modality
- Orthosteric Ligands
01
Overview
A Phase 2 trial of danazol in diabetic macular edema (DME), sponsored by Ampio Pharmaceuticals, Inc.. Started Feb 2013; status: completed.
02
Drugs
danazol
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT01821677.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01821677.